MARKER THERAPEUTICS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
MARKER THERAPEUTICS, INC. (MRKR) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$1.29 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-03-31
- MARKER THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$1.29M, a 182.78% decline from fiscal 2023.
- MARKER THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.56M.
- MARKER THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$2.86M.
- MARKER THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was -$8.77M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$1.29M 10-K · filed 2025-03-31 | |
| 2023-12-31 | $1.56M 10-K · filed 2025-03-31 | |
| 2022-12-31 | -$2.86M 10-K · filed 2024-03-26 | -$5.01M 10-K · filed 2023-03-22 |
| 2021-12-31 | -$8.77M 10-K · filed 2023-03-22 | |
| 2020-12-31 | -$5.06M 10-K · filed 2022-03-17 | |
| 2019-12-31 | -$4.68M 10-K · filed 2021-03-09 | |
| 2018-12-31 | -$8.07M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $1.91M 10-K · filed 2019-03-15 | $2.89M 10-K · filed 2018-03-23 |
| 2016-12-31 | $2.97M 10-K · filed 2018-03-23 | |
| 2015-12-31 | -$1.65M 10-K · filed 2017-03-14 | |
| 2014-12-31 | $1.26M 10-K · filed 2016-04-14 | |
| 2013-12-31 | $1.32M 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |